Scientists test pill & radiation combo for tough breast cancer
NCT ID NCT03109080
Summary
This early-stage trial tested the safety of combining a pill called olaparib with standard radiation therapy. It involved 24 women with advanced or hard-to-treat triple-negative breast cancer that had not fully responded to prior chemotherapy. The main goal was to find the highest dose of olaparib that could be safely given alongside radiation without causing severe side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RADIOTHERAPY SIDE EFFECT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut Curie
Paris, 75005, France
Conditions
Explore the condition pages connected to this study.